Herein we show for the first time that treatment post-MI with the apoA-I peptide mimetic L-4F, when initiated after the peak inflammatory response in a clinically-relevant I/R model, suppressed pro-inflammatory monocytes and macrophages and had beneficial effects on post-MI cardiac remodeling. This evidence concerns the gene APOA1 and myocardial infarction.